Stock Track | Argenx Soars 9% Pre-Market as Q3 Earnings Smash Expectations

Stock Track

2024/10/31

Shares of Argenx SE (NASDAQ: ARGX) surged over 9% in pre-market trading on Wednesday after the biopharmaceutical company reported stellar third quarter 2024 financial results that trounced analysts' estimates.

For the quarter ended September 30, Argenx posted earnings per share of $1.39, obliterating the consensus estimate of just $0.02. The company's revenue of $588.9 million also surpassed expectations, coming in 9.35% higher than the $538.5 million analysts had forecast.

The blockbuster Q3 results marked a sharp turnaround from the year-ago period when Argenx lost $1.25 per share. Sales skyrocketed 73% year-over-year as well, underscoring the remarkable growth trajectory the biotech firm is on.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1127565533"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127565533\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127565533?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127565533","market":"hk","top_or_hot":-1,"title":"Stock Track | Argenx Soars 9% Pre-Market as Q3 Earnings Smash Expectations","media":"Stock Track","content":"<p>Shares of Argenx SE (NASDAQ: ARGX) surged over 9% in pre-market trading on Wednesday after the biopharmaceutical company reported stellar third quarter 2024 financial results that trounced analysts' estimates.</p>\n\n<p>For the quarter ended September 30, Argenx posted earnings per share of $1.39, obliterating the consensus estimate of just $0.02. The company's revenue of $588.9 million also surpassed expectations, coming in 9.35% higher than the $538.5 million analysts had forecast.</p>\n\n<p>The blockbuster Q3 results marked a sharp turnaround from the year-ago period when Argenx lost $1.25 per share. Sales skyrocketed 73% year-over-year as well, underscoring the remarkable growth trajectory the biotech firm is on.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Argenx Soars 9% Pre-Market as Q3 Earnings Smash Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Argenx Soars 9% Pre-Market as Q3 Earnings Smash Expectations\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-10-31 16:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Argenx SE (NASDAQ: ARGX) surged over 9% in pre-market trading on Wednesday after the biopharmaceutical company reported stellar third quarter 2024 financial results that trounced analysts' estimates.</p>\n\n<p>For the quarter ended September 30, Argenx posted earnings per share of $1.39, obliterating the consensus estimate of just $0.02. The company's revenue of $588.9 million also surpassed expectations, coming in 9.35% higher than the $538.5 million analysts had forecast.</p>\n\n<p>The blockbuster Q3 results marked a sharp turnaround from the year-ago period when Argenx lost $1.25 per share. Sales skyrocketed 73% year-over-year as well, underscoring the remarkable growth trajectory the biotech firm is on.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARGX","symbol_name":"Argenx SE","start_time":0,"source_url":"","article_id":"1127565533","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127565533","pubTimestamp":1730364378,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Argenx SE  surged over 9% in pre-market trading on Wednesday after the biopharmaceutical company reported stellar third quarter 2024 financial results that trounced analysts' estimates.For the quarter ended September 30, Argenx posted earnings per share of $1.39, obliterating the consensus estimate of just $0.02. The company's revenue of $588.9 million also surpassed expectations, coming in 9.35% higher than the $538.5 million analysts had forecast.The blockbuster Q3 results marked a s","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARGX":"Argenx SE"},"translate_title":"股票赛道Argenx盘前飙升9%，第三季度盈利超出预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARGX":1},"content_text":"Shares of Argenx SE (NASDAQ: ARGX) surged over 9% in pre-market trading on Wednesday after the biopharmaceutical company reported stellar third quarter 2024 financial results that trounced analysts' estimates.\nFor the quarter ended September 30, Argenx posted earnings per share of $1.39, obliterating the consensus estimate of just $0.02. The company's revenue of $588.9 million also surpassed expectations, coming in 9.35% higher than the $538.5 million analysts had forecast.\nThe blockbuster Q3 results marked a sharp turnaround from the year-ago period when Argenx lost $1.25 per share. Sales skyrocketed 73% year-over-year as well, underscoring the remarkable growth trajectory the biotech firm is on.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}